← Eichor
Study identifier: NCT07123025 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Outcome of Partial Pulpotomy in Moderate and Severe Pulpitis

Condition: Moderate Pulpitis · Severe Pulpitis · Extremely Deep Caries  ·  Sponsor: Postgraduate Institute of Dental Sciences Rohtak

PhaseNA
Planned participants120
Who can joinAll sexes, 15 Years to 40 Years
Healthy volunteersYes

About this study

The aim of the study is to compare the outcome of Partial Pulpotomy in mature permanent teeth with moderate and severe pulpitis. OBJECTIVE: Primary objective- to compare the difference in clinical and radiographic outcome of partial pulpotomy in mature permanent teeth with moderate and severe Pulpitis. Secondary objective- To evaluate and compare OHRQoL and postoperative pain after Partial Pulpotomy in teeth with Moderate Pulpitis and Severe Pulpitis. Subjects of age group 15 to 40 years will be included and divided into two groups 1. Permanent mature molars with Moderate Pulpitis 2. Permanent mature molars with Severe Pulpitis

This description comes directly from the study's public registry record.

Talk to the study team

Dr. Pankaj Sangwan, MDS  ·  9996112202  ·  drps_1@yahoo.co.in

Dr. Prerna Yadav, PG student  ·  9763276071  ·  viks0267@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

PGIDS RohtakRohtak, Haryana, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07123025